Company Bangi Inc.

BNGI

US05989W1036

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Alternative Medicine

Delayed OTC Markets Other stock markets 12:41:27 2024-05-10 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2020	Bangi Inc. Announces Executive Changes	CI
2019	Bangi Inc. Launches Acquisition Strategy with Purchase of Cannabis Processing Facility	CI

Bangi Inc. is focused on the acquisition, ownership and management of properties leased to experienced, state-licensed operators for regulated use of Cannabis facilities. The Company intends to acquire properties through sale-leaseback transactions and third-party purchases.

Managers	Title	Age	Since
Nicole Birch CEO	Chief Executive Officer	-	20-04-17
Mathew Knowles SAM	Sales & Marketing	-	19-07-21

Members of the board	Title	Age	Since
Nicole Birch CEO	Chief Executive Officer	-	20-04-17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	5,561,487,035	5,505,872,165 ( 99.00 %)	0	99.00 %

BANGI, Inc.

41000 Woodward Avenue Suite 350 East

48304, Bloomfield Hills

+833-251-7679

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Alternative Medicine

	1st Jan change	Capi.
BANGI INC.	0.00%	8.06K
DONG-E-E-JIAO CO.,LTD.	+43.17%	6.29B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-14.69%	4.55B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+6.95%	3.27B
TASLY PHARMACEUTICAL GROUP CO., LTD	-8.17%	3.23B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-1.76%	2.56B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+50.20%	2B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.85%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-0.40%	1.64B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+54.97%	1.6B

Alternative Medicine